BioSpace News Archive

The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will be making an important announcement at the Tobacco Control Forum to mark World No-Tobacco Day.

The National Organization for Rare Disorders (NORD) today launched RareInsights™.

Children who undergo surgery for congenital heart disease have lower survival rates by three years of age if there are specific problems during fetal development.

Don Kania, Ph.D., has been appointed to the Board of Directors of Aldevron

The U.S Food and Drug Administration (FDA) today approved the first stand-alone prosthetic iris in the United States.

Officials from Health Canada will hold a technical briefing to discuss the upcoming proposed re-evaluation decision on imidacloprid’s effects on pollinators.

Statement from FDA Commissioner Scott Gottlieb, M.D., on federal preparedness and FDA’s response efforts to the Ebola virus outbreak in the Democratic Republic of Congo

Microbiome Insights, Inc. has announced the opening of its new laboratory on the campus of the University of British Columbia (UBC).

Pfizer Inc. announced that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ® (tofacitinib) 10 mg twice-daily (BID) for at least eight weeks, followed by XELJANZ 5 mg BID or 10 mg BID, for the treatment of adult patients in the U.S. with moderately to severely active ulcerative colitis (UC).

At the Annual General Meeting of RaySearch Laboratories AB (publ) held on May 30, 2018, several resolutions were adopted.